|Welcome to Elona Biotechnologies, Inc.
ELONA Biotechnologies, Inc. offers clients the vast experience of its world-class scientists for contract protein expression, purification, and characterization. Elona has become one of the biotechnology industry’s fastest growing companies worldwide because of the remarkable service, technical capabilities, quality and results we deliver. Since 1997, Elona has been helping companies get their proof-of-concept into and through clinical trials. Our expertises in proteomics, protein purification, process development, and regulatory support have allowed companies to further their products to commercialization.
A New State-of-the-Art Facility with 50,000 s.f. and Cutting Edge Equipment
In addition to our current corporate headquarters in Greenwood, Indiana, Elona Biotechnologies has constructed a brand new state-of-the-art 50,000 s.f. production facility on an 8-acre site in Greenwood. The newly constructed multi-million dollar facility has 13,000 square feet of office space, including three conference rooms. Elona Biotech has purchased brand new cutting-edge testing and research equipment to provide their staff of talented scientists and researchers the best equipment on the market with which to work. read more...
Contract Protein Expression, Purification, Characterization & More
ELONA is based in a state-of-the-art cGMP facility outside of Indianapolis, Indiana, USA which has the capacity to purify and fully characterize proteins as reagents and to independently produce a diverse range of clinical trial materials.
ELONA can also provide regulatory affairs expertise and comprehensive quality assurance programs as you require.
Our Talented Scientists and Researchers are the Best in the Biotechnology Industry
ELONA Biotechnologies, Inc. offers clients the vast experience of its world-class scientists for contract protein expression, purification, and characterization. Because of our non-heirarchical organization with a vibrant entreprenurial culture, Elona clients have more direct access to the scientists working on their project. read more...